Related Experiment Video

Updated: Sep 30, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

In vitro assessment of antiborrelial activity of OspA vaccine sera

Paul T Fawcett1, Carlos D Rose, Kathleen M Gibney

  • 1Immunology Laboratory, Department of Research, A. I. duPont Hospital for Children, Wilmington, Delaware 19803, USA. pfawcett@nemours.org

Clinical and Diagnostic Laboratory Immunology
|July 3, 2002
PubMed

Insights

A new assay can determine when booster doses are needed for Lyme disease vaccines. This method helps maintain protection against Borrelia burgdorferi transmission from ticks.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Lyme disease is transmitted by ticks carrying Borrelia burgdorferi.
  • Recombinant OspA-based vaccines aim to prevent spirochete transmission.
  • Determining optimal vaccination schedules is crucial for sustained immunity.

Purpose of the Study:

  • To develop and validate an in vitro assay.
  • To assess the need for booster doses of Lyme disease vaccine.
  • To provide an indicator for maintaining vaccine efficacy.

Main Methods:

  • Development of an in vitro microculture assay.
  • Utilizing the assay to evaluate immune response indicators.
  • Correlating assay results with vaccine effectiveness.

Main Results:

  • The microculture assay provides an indicator for booster dose necessity.
  • The assay can be used to monitor vaccine-induced immune status.
  • Demonstrated utility in assessing the need for revaccination.

Conclusions:

  • The developed in vitro assay is a valuable tool for managing Lyme disease vaccination.
  • This assay can help optimize booster dose timing for OspA-based vaccines.
  • Ensures sustained protection against Lyme disease transmission.

More Related Videos

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D08:15

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

Published on: December 9, 2022

Related Concept Videos